Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Intestinal microbiota and innate immunity-related gene alteration in cirrhotic rats with liver transplantation.
Xie YR, Liu SL, Liu X, Luo ZB, Zhu B, Li ZF, Li LJ, He Y, Jiang L, Li H, Ruan B.
Transplant Proc. 2011 Dec;43(10):3973-9.
Related citations
Orthotopic liver transplantation in critically ill cirrhotic patients with multi-organ failure: a single-center experience.
Umgelter A, Lange K, Kornberg A, Büchler P, Friess H, Schmid RM.
Transplant Proc. 2011 Dec;43(10):3762-8.
Liver transplantation in patients with cryptogenic cirrhosis: long-term follow-up.
Álamo JM, Bernal C, Barrera L, Marín LM, Suárez G, Serrano J, Gómez MA, Padillo FJ.
Transplant Proc. 2011 Jul-Aug;43(6):2230-2.
Toll-like receptor 3 L412F polymorphism may protect against acute graft rejection in adult patients undergoing liver transplantation for hepatitis C-related cirrhosis.
Citores MJ, Baños I, Noblejas A, Rosado S, Castejon R, Cuervas-Mons V.
Transplant Proc. 2011 Jul-Aug;43(6):2224-6.
Infections and organ transplantation: new challenges for prevention and treatment of hepatitis C virus.
Burra P, De Martin E.
Transplant Proc. 2011 Jul-Aug;43(6):2455-6. Review.
Concurrent inferior vena cava and hepatic vein stenoses after orthotopic liver transplantation: a case report.
Kim CY, Kim DS, Um SH, Park BJ, Cho SB, Kim YH, Suh SO.
Transplant Proc. 2011 Jul-Aug;43(6):2421-3.
Effectiveness and safety of everolimus in the treatment of autoimmune hepatitis related to anti-hepatitis C virus therapy after liver transplant: three case reports.
Casanovas T, Argudo A, Peña-Cala MC.
Transplant Proc. 2011 Jul-Aug;43(6):2233-6.
End-stage liver cirrhosis with severe autoimmune hemolytic anemia, treated by blood type-incompatible living donor liver transplantation: a case report.
Sanefuji K, Ikegami T, Nagata S, Sugimachi K, Gion T, Uchiyama H, Soejima Y, Taketomi A, Shirabe K, Maehara Y.
Transplant Proc. 2011 Jun;43(5):2087-9.
Superparamagnectic iron oxide-enhanced magnetic resonance for tumor surveillance in cirrhotic liver before liver transplantation with explanted liver correlation.
Tsang LL, Chen CL, Huang TL, Chen TY, Ou HY, Eng HL, Concejero A, Yu CY, Chen HL, Cheng YF.
Transplant Proc. 2011 Jun;43(5):1674-7.
Effect of propranolol on the relationship between QT interval and vagal modulation of heart rate variability in cirrhotic patients awaiting liver transplantation.
Kim YK, Hwang GS, Shin WJ, Bang JY, Cho SK, Han SM.
Transplant Proc. 2011 Jun;43(5):1654-9.
A perspective on cirrhotic cardiomyopathy.
Timoh T, Protano MA, Wagman G, Bloom M, Vittorio TJ.
Transplant Proc. 2011 Jun;43(5):1649-53. Review.
Oral health profile of cirrhotic patients awaiting liver transplantation in the Brazilian Northeast.
Lins L, Bittencourt PL, Evangelista MA, Lins R, Codes L, Cavalcanti AR, Paraná R, Bastos J.
Transplant Proc. 2011 May;43(4):1319-21.
Examination of claudin-1 expression in patients undergoing liver transplantation owing to hepatitis C virus cirrhosis.
Zadori G, Gelley F, Torzsok P, Sárváry E, Doros A, Deak AP, Nagy P, Schaff Z, Kiss A, Nemes B.
Transplant Proc. 2011 May;43(4):1267-71.
Intensive care unit admission of decompensated cirrhotic patients: prognostic scoring systems.
Feltracco P, Brezzi M, Barbieri S, Milevoj M, Galligioni H, Cillo U, Zanus G, Vitale A, Ori C.
Transplant Proc. 2011 May;43(4):1079-84.
Validation of 20-meter corridor for the 6-minute walk test in men on liver transplantation waiting list.
Veloso-Guedes CA, Rosalen ST, Thobias CM, Andreotti RM, Galhardo FD, Oliveira da Silva AM, Araujo O, Boin IF.
Transplant Proc. 2011 May;43(4):1322-4.
Relationship between hepatitis C virus recurrence and de novo diabetes after liver transplantation: the Hungarian experience.
Gelley F, Zadori G, Firneisz G, Wagner L, Fehervári I, Gerlei Z, Fazakas J, Papai S, Lengyel G, Sarvary E, Nemes B.
Transplant Proc. 2011 May;43(4):1281-2.
Cystatin C level as a predictor of death and cardiovascular events after liver transplantation.
Bernal V, Pascual I, Piazuelo E, Esquivias P, Fernandez C, Garcia-Gil FA, Simon MA.
Transplant Proc. 2011 Apr;43(3):732-4.
Strategies of immunosuppression for liver transplant recipients with hepatocellular carcinoma.
Castroagudín JF, Molina-Pérez E, Ferreiro-Iglesias R, Varo-Pérez E.
Transplant Proc. 2011 Apr;43(3):711-3.
Large benign hepatocellular nodules in cirrhosis due to chronic venous outflow obstruction: diagnostic confusion with hepatocellular carcinoma.
Oliveira EC, Duarte AG, Boin IF, Almeida JR, Escanhoela CA.
Transplant Proc. 2010 Dec;42(10):4116-8.
Liver transplantation in a randomized controlled trial of emergency treatment of acutely bleeding esophageal varices in cirrhosis.
Orloff MJ, Isenberg JI, Wheeler HO, Haynes KS, Jinich-Brook H, Rapier R, Vaida F, Hye RJ, Orloff SL.
Transplant Proc. 2010 Dec;42(10):4101-8.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on